Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 29, 2015 8:11 PM ET

Biotechnology

Company Overview of Fusion IP plc

Company Overview

Fusion IP plc, through its subsidiaries, commercializes intellectual property (IP) that is developed at universities and similar establishments through the formation of, and investment in, spin-out companies in the United Kingdom. It has agreements with the University of Sheffield, the Cardiff University, the University of Nottingham, and Swansea University. The company also has a portfolio of approximately 20 companies in a range of engineering, nanotechnology, software, and medical sectors. In addition, it develops orphan drugs, cancer diagnostics and therapeutics, advanced wound care, novel new pharmaceuticals, and antibody therapies, as well as is involved in designing and testing micron...

The Sheffield Bioincubator

40 Leavygreave Road

Sheffield,  S3 7RD

United Kingdom

15 Employees

Key Executives for Fusion IP plc

Operations Director and Director
Age: 56
Company Secretary
Commercial Director and Director
Age: 52
Compensation as of Fiscal Year 2015.

Fusion IP plc Key Developments

Fusion IP plc Reports Preliminary Consolidated Earnings Results for the Full Year Ended July 31, 2013

Fusion IP plc reported preliminary consolidated earnings results for the full year ended July 31, 2013. Total revenue and portfolio returns decreased to £3,035,000 from £4,750,000 last year, due to both a reduction in revenue and fewer funding rounds leading to lower net fair value gains on investments. Revenue, which includes the amounts charged to non-subsidiary spin-out companies for management services provided, license income and income generated by consolidated companies, decreased to £540,000 from £705,000 reported last year. The decrease relates to reduced revenue in subsidiaries. Loss from operating activities was £1,366,000 against income from operating activities of £390,000 last year. Loss before taxation was £1,204,000 against profit before taxation of £505,000 last year. The group generated an operating profit (excluding subsidiary spin-out costs and amortization) of £1,250,000 against £3,042,000 last year. Loss and total comprehensive loss attributable to owners of the parent was £959,000 or 1.14 pence per basic and diluted share against profit and total comprehensive profit attributable to owners of the parent of £669,000 or 1.00 pence per basic and diluted share last year. Net cash flows used in operating activities was £1,908,000 against £2,066,000 last year. Purchase of property, plant and equipment was £12,000 against £8,000 last year.

Fusion IP plc to Report Fiscal Year 2013 Results on Oct 15, 2013

Fusion IP plc announced that they will report fiscal year 2013 results on Oct 15, 2013

Similar Private Companies By Industry

Company Name Region
Team Consulting Limited Europe
Cambridge Biotransforms Limited Europe
Momentum Bioscience Ltd Europe
EvoCell Ltd. Europe
Oxyrane UK Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Fusion IP plc, please visit www.biofusion.co.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.